QUESTRAN LIGHT

LOE Approaching

cholestyramine

NDAORALPOWDER
Approved
Dec 1988
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
3

Clinical Trials (3)

NCT05894928Phase 1Completed

A Study to Evaluate the Effect of Cholestyramine on LOXO-783 in Healthy Participants

Started Jun 2023
21 enrolled
Healthy
NCT04235205Phase 2Completed

Efficacy and Safety of Elobixibat in Combination With Cholestyramine for Nonalcoholic Fatty Liver Disease

Started Jan 2020
NCT01122108Phase 4Completed

Comparison of Colesevelam Hydrogen Chloride (HCl) Powder For Oral Suspension Versus Generic Cholestyramine Through Use of the Bile Acid Sequestrant Acceptability (BASA) Scale

Started Apr 2010
42 enrolled
Healthy